Company Overview and News

 
RCI may revive plans for solar power plant

2018-05-27 bworldonline
ROXAS and Company, Inc. (RCI) may revisit its plan of building a 50-megawatt solar power plant some time this year, a top official said.
RCI

 
RCI pins growth hopes on property, coconut processing

2018-05-23 bworldonline
ROXAS and Company, Inc. (RCI) expects its business ventures to stabilize in 2018, banking on its property projects and coconut processing plant to drive growth in the coming years.
RCI RLC RBLAY

 
RCI looking to ‘stabilize’ this year

2018-05-23 bworldonline
Roxas and Company, Inc. (RCI) expects its business ventures to stabilize in 2018, banking on its property projects and coconut processing plant to drive growth in the coming years.
RCI

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to PSE:RCI / Roxas and Company, Inc. on message board site Silicon Investor.

A Review of TV Commercials: The Good, The Bad, u0026 The Ugly A Review of TV Commercials: The Good, The Bad, u0026 The Ugly A Review of TV Commercials: The Good, The Bad, u0026 The Ugly Commercial Real Estate tic.............tic,,, Commercial Real Estate tic.............tic,,, Commercial Real Estate tic.............tic,,,
Interesting Commercials on TV, Radio u0026 Print Interesting Commercials on TV, Radio u0026 Print Interesting Commercials on TV, Radio u0026 Print SourcingLink.net, Inc. SourcingLink.net, Inc. SourcingLink.net, Inc.
Sparta Commercial Services Sparta Commercial Services Sparta Commercial Services Commercial and Home Battery Back Up Commercial and Home Battery Back Up Commercial and Home Battery Back Up
Donu0027t abuse it, reuse it! ARCI makes the big comeback. Donu0027t abuse it, reuse it! ARCI makes the big comeback. Donu0027t abuse it, reuse it! ARCI makes the big comeback. Computer Outsourcing Services Inc. (NASDAQ:COSI) Computer Outsourcing Services Inc. (NASDAQ:COSI) Computer Outsourcing Services Inc. (NASDAQ:COSI)
GENROCO: OTC:BB GRCI GENROCO: OTC:BB GRCI GENROCO: OTC:BB GRCI BOOMER NOSTALGIA - EXTINCT COMMERCIALS REMEMBERED BOOMER NOSTALGIA - EXTINCT COMMERCIALS REMEMBERED BOOMER NOSTALGIA - EXTINCT COMMERCIALS REMEMBERED